Showing results (71-80 of 103) with videos related to
Sort By:
Pageof 11
Pharmacotherapy|September 1, 1996
The pharmacologic effects of recombinant, human colony-stimulating factors and their modulation by theophyllineW P Petros, G L Rosner, J Rabinowitz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancerW P Peters, E J Shpall, R B Jones, et al.The Journal of Infectious Diseases|May 1, 1992
Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipientsJ R Perfect, M E Klotman, C C Gilbert, et al.Journal of Hematotherapy|June 1, 1996
The significance of microbial cultures of the hematopoietic support for patients receiving high-dose chemotherapyA Cohen, M Tepperberg, B Waters-Pick, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 1, 1997
The significance of tumor contamination in the bone marrow from high-risk primary breast cancer patients treated with high-dose chemotherapy and hematopoietic supportJ J Vredenburgh, O Silva, G Broadwater, et al.Bone Marrow Transplantation|July 1, 1996
Thrombotic microangiopathy as a complication of high-dose chemotherapy for breast cancerD C Fisher, G B Sherrill, A Hussein, et al.Journal of Hematotherapy|February 1, 1996
A comparison of immunohistochemistry, two-color immunofluorescence, and flow cytometry with cell sorting for the detection of micrometastatic breast cancer in the bone marrowJ J Vredenburgh, O Silva, C Tyer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1997
Relation of glutathione S-transferase alpha and mu isoforms to response to therapy in human breast cancerL C Alpert, R L Schecter, D A Berry, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Impact of consolidation radiotherapy in patients with advanced breast cancer treated with high-dose chemotherapy and autologous bone marrow rescueD L Carter, L B Marks, J M Bean, et al.Cancer Treatment Reports|February 1, 1987
High-dose combination alkylating agent preparative regimen with autologous bone marrow support: the Dana-Farber Cancer Institute/Beth Israel Hospital experienceK Antman, J P Eder, A Elias, et al.Pageof 11